
PLOS Digital Health, Journal Year: 2025, Volume and Issue: 4(4), P. e0000776 - e0000776
Published: April 8, 2025
Background The World Health Organization (WHO) has proposed the concept of mobile health to support healthcare systems delivery worldwide. Mobile (mHealth) involves using Information and Communication Technology (ICT) for care provision or services. In context Africa, a region that witnessed significant increase in phone availability usage last decade corresponding rise incidence prevalence diabetes mellitus, this study global implications. We conducted systematic review on extent mHealth implementation managing mellitus Africa. estimated its impact achieving desired glycemic targets, sustained control, preventing complications past decade. Methods analysis studies assessing utilization patients with Africa were considered based PICO method: Population, Intervention, Comparator, Outcomes. MEDLINE, PubMed, SCOPUS, Pan African Clinical Trials Registry searched. Two authors, independent each other, screened titles abstracts retrieved search strategy, full-text articles, assessed them eligibility, extracting data after that. A third reviewer was brought resolve disagreements between two authors by discussion. revised Cochrane Collaboration Risk Bias Tool used assess quality included studies. narrative synthesis extracted done due paucity eligible studies, results summarized meta-analysis. Results None six measured mean FPG percentage changes as primary outcomes. Five change HbA1c from baseline end study. ranged 3.6% 20.53%, significance three meta-analysis overall WMD (95% CI) 0.992 (0.48, 1.50). This, combination high z score 3.822, p <0.001 suggests statistically effect is not likely chance. However, considerable heterogeneity (I 2 = 63.9%, 0.026) present implying observed may be generalizable all differences characteristics case most sample size duration addressed secondary outcomes measuring direct relationships these interventions prevention early detection complications. Conclusion Overall, there reduction levels among individuals living type following interventions. Few heterogeneity. Therefore, we recommend more well-designed randomized controlled trials investigate efficacy management Systematic registration PROSPERO CRD42021218674
Language: Английский